- $5.3 trillion: U.S. health spending in 2024
- $25 billion: Annual cost of denied insurance claims
- $15/month: Discounted Pro plan for underserved patients
Experts would likely conclude that ProjectLeo's AI-driven patient advocacy app represents a bold, privacy-focused challenge to the healthcare status quo, with potential to improve equity but requiring rigorous oversight to avoid perpetuating biases.
ProjectLeo's AI Enters the Fray Against a Broken Healthcare System
CHICAGO, IL – June 24, 2026 – For anyone who has felt lost in the labyrinth of the American healthcare system—confused by a medical bill, overwhelmed by a diagnosis, or defeated by an insurance denial—a Chicago-based startup believes it has an answer. And it fits in your pocket.
Today, ProjectLeo launched its AI-powered patient advocacy app, a tool designed to serve as a 24/7 independent guide for patients and their caregivers. The launch marks the entry of a new player into the burgeoning health-tech field, but with a mission that seems to run counter to the industry's prevailing winds. Instead of serving hospitals or insurers, ProjectLeo is built exclusively for the patient.
"I spent years watching people get left behind by a system that was never designed with them in mind," said Charlie Alfarah, Founder and CEO of ProjectLeo. "I built ProjectLeo because no one should have to navigate their healthcare alone. Leo is built for the patient in the waiting room who doesn't understand why their claim was denied — or what to do next."
This sentiment cuts to the heart of a widespread crisis. With U.S. health spending hitting $5.3 trillion in 2024 and four in ten adults carrying medical debt, the system's financial and emotional toll is immense. ProjectLeo is betting that artificial intelligence can be the great equalizer, a digital advocate that works for the individual, not the institution.
An Advocate in Your Pocket
At its core, the ProjectLeo app provides a conversational AI, named Leo, that operates across six distinct modes: Navigator, Ally, Educator, Analyst, Coordinator, and Wellness Coach. The goal is to demystify healthcare from nearly every angle. The app connects directly to a user's electronic health records through secure, FHIR-compliant integrations, allowing it to work with a patient's actual medical history.
The 'Educator' mode can take a complex lab result or diagnosis and translate it into plain language. The 'Analyst' can review health data to surface patterns, while the 'Coordinator' helps manage communications with a sprawling care team. For many, the most critical functions will be the most practical. The app can help users prepare questions for a doctor's visit and, with its Pro tier, provide summaries of the appointment afterward.
Perhaps its most ambitious feature is its ability to tackle the bureaucratic nightmare of insurance. The Pro version of the app is designed to read a claim denial letter, explain the reasoning, identify the strongest grounds for an appeal, and even draft a personalized appeal letter for the user. In a system where denied claims cost patients and providers over $25 billion in appeals alone, this function could be a game-changer for individuals lacking the time or expertise to fight back.
Underpinning these features is a commitment to accessibility. A multilingual voice mode with real-time translation aims to break down language barriers, a significant obstacle to equitable care for many immigrant communities—a reality the founder, born into an immigrant family, knows well.
A Patient-First Model in a Data-Hungry World
While the app's features are compelling, its business model may be its most disruptive innovation. In an era where personal data is often considered the new oil, ProjectLeo has adopted a firm, public stance: "Patient data is never sold to insurers, hospital systems, or pharmaceutical companies."
This is a radical departure from the norm. The health-tech landscape is filled with platforms that, while offering valuable services, often generate revenue by providing anonymized data and analytics to the very institutions patients struggle to navigate. ProjectLeo eschews this model entirely, opting for a direct-to-consumer subscription service priced at $29/month for an 'Essentials' plan and $49/month for the 'Pro' tier.
This patient-first, privacy-centric approach is a direct challenge to the status quo. "The company's entire philosophy seems to be built on earning patient trust in an industry where that trust has been deeply eroded," noted one health data privacy expert. By building its revenue model around user subscriptions rather than data monetization, the company aligns its success directly with patient satisfaction. Its privacy policy reinforces this, stating data is used "only as necessary to provide, maintain, and improve the Services and support your healthcare advocacy."
This model differentiates ProjectLeo from competitors. While other services connect patients with human advocates, sometimes augmented by AI, Leo is positioned as a direct-to-patient, fully AI advocate. This creates a scalable, always-on solution, though it forgoes the human touch that some patients may prefer. The critical question is whether a subscription model can be sustainable while resisting the lucrative allure of the healthcare data market.
Can AI Bridge the Healthcare Divide?
Beyond its business model, ProjectLeo's most significant potential impact lies in its stated mission to address systemic inequality. The statistics are stark: Black patients are referred to fewer specialists than White patients, and medical debt disproportionately burdens low-income households. The complexity of the system itself is a barrier, and those without resources are often the most vulnerable.
ProjectLeo confronts this challenge head-on with its Healthcare Access Program. Patients receiving Medicaid, SNAP, or other forms of government assistance can apply to get the Essentials plan for free, or the Pro plan for a steeply discounted $15 per month. This initiative moves beyond rhetoric, creating a tangible pathway for underserved populations to access the same powerful advocacy tools.
This focus on equity is deeply embedded in the company's DNA, stemming from founder Charlie Alfarah's background as a Certified Diversity Professional and his own lived experiences. The goal is to leverage AI to level the playing field, providing sophisticated support to those who could never afford a private human advocate.
However, the promise of AI in promoting health equity is not without its perils. Experts caution that AI models trained on biased data sets can inadvertently perpetuate the very disparities they aim to solve. The success of ProjectLeo's mission will depend not only on its technology's effectiveness but also on a continued, rigorous commitment to transparency and fairness in its algorithms.
The launch of Leo represents more than just a new app on the market. It is an experiment in redefining the relationship between patients, technology, and the healthcare industry. Its success will be measured not in downloads, but in its ability to empower individuals and prove that a business can thrive by putting the patient, and their privacy, first.
